Efficacy of intravitreal bevacizumab after unresponsive treatment with intravitreal ranibizumab. [electronic resource]
Producer: 20110909Description: 182-5 p. digitalISSN:- 1715-3360
- Angiogenesis Inhibitors -- administration & dosage
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized
- Bevacizumab
- Choroidal Neovascularization -- diagnosis
- Female
- Fluorescein Angiography
- Follow-Up Studies
- Humans
- Intravitreal Injections
- Macular Degeneration -- diagnosis
- Male
- Ranibizumab
- Retreatment
- Retrospective Studies
- Tomography, Optical Coherence
- Treatment Failure
- Treatment Outcome
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
- Visual Acuity -- physiology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.